Skip to search.
 TSX Down 0.08% TSX Ventures Up 0.73%

XOMA Corporation (XOMA)

-NasdaqGM
0.88 Down 0.06(6.63%) Feb 5, 4:00PM EST
Prev Close:0.94
Open:0.93
Bid:0.85 x 1500
Ask:0.95 x 5000
1y Target Est:2.46
Beta:3.0637
Earnings Date:Mar 9 - Mar 14 (Est.)
Day's Range:0.86 - 0.94
52wk Range:0.69 - 4.93
Volume:1,444,570
Avg Vol (3m):2,684,150
Market Cap:104.49M
P/E (ttm):N/A
EPS (ttm):-0.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
XOMADown 6.63%104.49M
REGNDown 3.87%42.06B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.64
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.54
Quarterly EPS Est (Dec-15) :-0.15
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-0.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company’s lead product candidate includes gevokizumab, a proprietary humanized allosteric-modulating monoclonal antibo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback